A class of ollgonucleotides which binds to naturallyoccurring duplex DNA sites at physiologic pH to form triple helical structures was used as transcription attenuators In an In vitro transcription assay. Ollgonucleotides were designed to form triple helices with a purlne-rlch, double-stranded target by binding in the major groove In an orientation anti-parallel to the most purlne-rich strand of the target. A 45 base-pair purine-rich region located within the gag gene of Friend Murine Leukemia Virus (FMLV) was used as the duplex target. The target DNA was Inserted by molecular cloning downstream of either the bacterial T7-or T3 promoter. The sequence-specific Interaction of the triple helix-forming oligonucleotlde (TFO) with the FMLV target was confirmed by DNAse I footprint analysis. The affinity of the TFO, as measured by the equilibrium dissociation constant of the TFO for the duplex, was determined by band shift analysis. When a TFO was allowed to form a triple helix with the target duplex In well-defined buffer conditions before the transcription reaction, truncated transcripts of a predicted size were observed. Attenuation of transcription was observed only when buffer conditions favorable to triple helix formation were used. In addition, ollgonucleotides containing a high percentage of guanoslne residues were able to inhibit mRNA production of the bacterial T7 polymerase by a mechanism Independent of transcription attenuation. The ability of an ollgonucleotide-dlrected triple helical structure to slow down, or even completely stop, RNA chain elongation may expand the utility of triple helix technology In the area of gene regulation.
INTRODUCTION
Synthetic oligonucleotides have been shown to bind to the major groove of duplex DNA at homopurine-homopyrimidine sequences in a sequence-dependent manner at physiologic pH, forming a local triple helix (1) (2) (3) . One potential application of triple helix-forming oligonucleotides (TFOs) is the regulation of gene expression (4) . For example, an oligonucleotide which formed a triple helix on a portion of the c-myc promoter was capable of inhibiting c-myc transcription in vitro (1, 5 )-At present, TFOs, which are designed to bind in an anti-parallel or parallel orientation relative to the purine-rich strand of the target duplex, have been limited to DNA targets located within the promoter regulatory regions of genes (1, (5) (6) (7) (8) . In theory, TFOs designed in this fashion inhibit gene expression by interfering with the initiation of transcription.
Restricting target selection to homopurine/homopyrimidine tracts within promoter regulatory regions of selected target genes greatly reduces the utility of the technology. Limitations in the target duplex to which triple helices could be formed may be overcome by easing the target constraints (homopurine/homopyrimidine restriction) or by increasing the available genetic sequences to which TFOs could be targeted. The latter approach would allow for the targeting of TFOs to greater stretches of DNA. In this scenario TFOs which bound to transcribed sections of the targeted genes could be used as attenuators of transcription.
Recently, Young et ed. (9) described a TFO-mediated attenuation of transcription in vitro, using a duplex target located downstream of the adenovirus major late promoter. However, using an in vitro bacteriophage T7 promoter system, Maher (10) was able to detect TFO-mediated inhibition of the T7 RNA polymerase transcription initiation but not inhibition of transcription elongation (attenuation). In the present study we describe assay conditions needed to obtain in vitro attenuation of transcription using TFOs.
Oligonucleotide synthesis and modification
All oligodeoxynucleotides used in this study were synthesized on an Applied Biosystems Inc. (ABI) 380B or 3942 DNA synthesizer, using standard phosphoramidite methods at 0.2 or 1.0 nM scales. Protected nucleoside 3'-phosphoramidites and other reagents were obtained from Milligen with the exception of acetonitrile, which was obtained from Baxter. All oligonucleotides were synthesized with a 3'-Amino Modifier (Glen Research), which results in the covalent attachment of a propanolamine group to the 3'-hydroxyl group of the oligonucleotides. The oligonucleotides were desalted on an Amicon TCF cell containing an appropriate size membrane filter (11) . The purity of the oligonucleotide was confirmed by analytical HPLC, electrophoresis of 32 P-labeled oligonucleotide on a 20% polyacrylamide gel containing 7 M urea, and by capillary electrophoresis analysis.
Recombinant plasmids
The plasmid pLRB215 containing the FMLV (clone 57) genome was kindly provided by S.Goff. The bacterial T7 polymerase vector (pT7-2) was purchased from United States Biochemical Corporation. The T3 polymerase vector pBluescript II KS + (pBS KS + ) was purchased from Stratagene. To generate recombinant plasmids containing a portion of the FMLV gag gene downstream from either the bacterial T7 or T3 promoters, the HindlH/Eco Rl fragment of FMLV (1.97 kb) was inserted between the Hind III and Eco Rl sites of pT7-2 or pBS KS + ( Figure 2C and 2D) using standard laboratory techniques (12) . The orientation and integrity of the insert DNA was confirmed by DNA sequence analysis (12) .
Band shift analysis
The affinity of oligonucleotides for the FMLV target duplex was determined using 'band shift' analysis as described by Durland et al. (2) . Band shift experiments were conducted by incubating trace concentrations of end-labeled target duplex with increasing concentrations of TFO (10~1 0 M to 10" 6 M) at 37 °C overnight. The annealing buffer for these assays consisted of 20 mM Tris-HCl, pH 7.6, 10 mM MgCl 2 and 10% sucrose. In some experiments, 50 mM NaCl or 50 mM KC1 was added to the annealing buffer. The midpoint in the titration of TFO at which the duplex target has shifted to a slower migrating species is the apparent equilibrium dissociation constant (K D ) for triplex formation (2) .
DNAse I footprinting analysis
The Hind m to Stu I (172 base-pair) fragment of FMLV ( Figure  2B ) was excised from p275A, filled in at the Stu I site using the Klenow fragment of E. coli DNA polymerase and a-32 P dTTP. Footprinting was performed as described by Durland et al. (2) . In these assays, target duplex was incubated with oligonucleotide for 4 hours at 37°C before the addition of DNAse I (0.125 units/ml) for 10 min at 37° C (2). The DNAse I cleavage pattern was analyzed by polyacrylamide gel electrophoresis.
In vitro transcription reactions
The recombinant plasmid DNAs p275A and pBSFMLV were cleaved to completion using Dde I, then treated with 50 /ig/ml of proteinase K for 30 min at 37 °C. The reaction mixtures were then extracted twice with an equal volume phenol xhloroform (24:1 chlolofornrisoamyl alcohol), precipitated in ethanol, then resuspended in a buffer containing 10 mM Tris-HC1 pH 7.6 and 0.1 mM EDTA. One /ig of Dde I-digested plasmid DNA was annealed in 10 /d, with various concentrations of test oligonucleotides, for 16-20 hours at 37°C. The oligonucleotide component consisted of test oligonucleotide plus G101-50 so that the total amount of oligonucleotide in each reaction was 4xlO" 6 M. The annealing reaction was performed in 20 mM Tris-HCl, pH 7.6 and 10 mM MgCl 2 -m several experiments the annealing buffer was modified by the addition of either 50 mM NaCl or 50 mM KC1. The annealed DNA (10 /il) was then incubated for 30 min at 37°C in a final volume of 20 (A consisting of 20 mM Tris-HCl, pH 7.6, 10 mM MgCl 2 , 0.5 mM GTP, ATP and CTP, 0.05 mM UTP, 1 /xl of [a-32 P]UTP (800 Ci/mMol), and 2 units of either T7 or T3 polymerase. The reactions were stopped by cooling and precipitated by the addition of ethanol. The RNA transcripts were analyzed by electrophoresis on a 10% denaturing polyacrylamide gel containing 7M urea.
RESULTS

Experimental design
The modification of the 3' terminal hydroxyl group of an oligonucleotide with an amine group has been shown to enhance nuclease resistance of these molecules in culture and in vivo (13) . For this reason, all oligonucleotides used in this study were synthesized so that a propanolamine group was attached at their 3' terminal hydroxyl group.
An oligonucleotide designed to form a triple helix (TFO) in an anti-parallel orientation (FMLV2ap) with the purine-rich target duplex (in the gag region of FMLV clone 57) is illustrated in Figure 1A . The purine-rich target spans nucleotides 931 to 975 of the FMLV genome (14) . Oligonucleotides containing only guanosine and thymidine bases generally form triple helices with their target duplex when aligned in an anti-parallel orientation (2, 3) . Therefore, when the orientation of FMLV2ap was inverted, the resulting parallel-oriented molecule (FMLV2p) did not bind to the FMLV target and was used as sequence isomer control ( Figure 1 ). The anti-parallel-oriented molecule (FMLV2ap), when bound to the viral genome, interacted with the non-coding strand such that the 5' terminus was oriented towards the incoming RNA polymerase. Other oligonucleotides used as controls in the various experiments (G101-50 and 1100-11) are shown in Figure 1 .
Binding affinity
The affinity of oligonucleotides for the FMLV target duplex was determined using band shift analysis as described by Durland et al. (2) . In this experiment, 32 P-end-labeled target duplex was incubated with increasing concentrations of oligonucleotide at 37°C overnight before electrophoresis through a polyacrylamide gel. The midpoint in the titration of TFO at which the duplex target shifts to a slower migrating species is the apparent equilibrium dissociation constant (K D ) for triplex formation (Figures 1 and 3) . The results of these assays demonstrated a tight interaction (10~9 M K D ) of FMLV2ap with the target duplex when no monovalent cation was present in the annealing buffer. However, when the assay was performed in the presence of 50 mM NaCl or KC1, the K D was much larger. This observed change in the K D in the presence of monovalent cations may be due to competition of the monovalent cation with the divalent Mg 2+ ions which results in the induction of inter- or intramolecular oligonucleotide associations, such as guanosine tetrads, mediated by hydrogen bonding between the guanosine residues (15). FMLV2p designed in the parallel orientation to the purine-rich strand of the duplex target did not bind to the double-stranded FMLV target and was used as an isomer control. 1100-11 and G101-50 did not bind to the duplex target.
DNAse I footprint analysis
A more rigorous analysis of the interaction between the TFOs and their corresponding duplex target was performed by DNAse I footprint analysis. Specific binding of TFOs to the FMLV target can be assessed by DNAse I footprinting in a manner similar to the analysis of DNA-protein interactions. In this experiment, a 172-base-pair (bp), Hind m/Stu I, fragment of FMLV ( Figure  2B ) was radiolabeled, incubated with FMLV2ap or FMLV2p, then digested with DNAse I, as described in Materials and Methods. The results of this experiment demonstrate that FMLV2ap interacts with the FMLV duplex target at the predicted binding site (Figure 3 ). The control oligonucleotide, which was similar in length, base composition and terminal structures, did not protect the target sequence from DNAse I digestion ( Figure  3 ). These data indicate that, within the limits of accuracy for DNAse I footprinting of triple helical nucleic acid structures, FMLV2ap bound to the duplex target as predicted.
In vitro transcription analysis
In order to assess the effects of the oligonucleotides on transcription, the 1973-bp Hind HI to Eco Rl subfragment of the FMLV genome ( Figure 2A ) was inserted into the bacterial expression vectors pT7-2 and pBluescript. The resulting plasmids ( Figure 2C and 2D) contained the TFO target sequence downstream from the bacterial T7 (p275A) or T3 (pBSFMLV) promoters. In plasmid p275A, the Hind EH site is 10 bp downstream of the T7 mRNA start site, the beginning of the purine-rich target is 63 bp 3' to the mRNA start site, and the Dde I site is 131 bp 3' to the mRNA start site ( Figure 2C ). When this plasmid is cleaved with Dde I and then used as a template in in vitro transcription reactions using the T7 polymerase, a 131-nucleotide (nt) run-off transcript is obtained. Plasmid pBSFMLV contains a Hind HI site 50 bp downstream of the T3 mRNA start site, the target sequence is 103 bp 3' to the mRNA start site, and the Dde I site is 171 bp 3' to the mRNA start site ( Figure 2D ). In vitro transcription reactions using Dde I-linearized pBSFMLV ad T3 polymerase results in the generation of a 171-nt transcript.
The recombinant plasmids were linearized with Dde I, incubated at room temperature overnight with or without oligonucleotide, then used as template for in vitro transcription reactions. The bacterial T7 (p275A) or T3 (pBSFMLV) polymerases were used in these assays. Radio-labeled [(a-32 P)UTP], full-length or truncated mRNA transcripts were analyzed by polyacrylamide gel electrophoresis, then quantitated by cutting out the specific transcript band and measuring the radioactivity in a scintillation counter.
In initial transcription experiments it was observed that a nonsequence-dependent inhibition of T7 RNA polymerase occurred when oligonucleotides containing a high percentage of guanosine residues were pre-incubated with p275A. For example, 1100-11, a random sequence oligonucleotide which contains only 25% Table 1 ). However, G101-50 (53% guanosine) consistently demonstrated minor inhibition of full-length T7 transcripts ( Figure 4A lanes 3 and 10, Table 1 ). In dose response assays, the level of G101-50 inhibition leveled off when concentrations in the range of 10~6M were used (data not shown). Therefore, to separate nonsequence-dependent inhibitory events from TFO-mediated inhibition, we used G101-50 as a carrier oligonucleotide in all transcription reactions. When 1100-11 was pre-incubated with p275A in the presence of G101-50 (to a final reaction concentration of 4xlO~6M oligonucleotide), the stimulatory effect of 1100-11 was still observed in a dose-dependent fashion ( Figure 4 and Table 1 ). However, when FMLV2p (64% guanosine) was pre-incubated with p275A in the presence of G101-50, an additional dose-dependent inhibition of T7 transcription was observed ( Figure 4A and Table 1 ). In assays designed to monitor the effects of 1100-11, G101-50 and FMLV2p on T7-directed transcription, no detectable accumulation of truncated transcripts (63 to 108 nt) was observed. This result, obtained in multiple experiments, implies that transcription inhibition by FMLV2p occurred via a mechanism independent of attenuation.
To investigate TFO-mediated transcription attenuation, Dde I-digested p275A was pre-incubated with FMLV2ap (2x 10~6 to 2 x 10 -9 M). In these assays, a dose-dependent decrease in the full-length (131 nt) transcript was observed, with a maximum decrease of approximately 80% when 2 x 10~6M or 2 x 10~7M FMLV2ap was used ( Figures 5A and 5B . The size of the transcripts, in nucleotides, was estimated using a radio-labeled double-stranded DNA marker. In the gel conditions used, the DNA standards were denatured so that the size estimates were based on the mobility of single-stranded DNA.
to the position of the TFO binding site (63-108 nt) was observed ( Figure 5A ). The control oligonucleotide G101-50 alone (4x 10~6M) decreased the amount of full-length transcripts by approximately 20%, but no accumulation of truncated mRNA was observed (Figures 4 and 5A) . The quann'tation of the relative amounts of accumulated truncated transcripts is presented in Figure 6 . It is interesting to note that the accumulated truncated transcripts did not account for the total decrease in full-length transcripts ( Figure 6 ). The data from this experiment, when plotted as the ratio of TFO to target duplex, suggests that maximum attenuation was achieved with an effector to target ratio of approximately 1:1 (data not shown).
A dose-dependent decrease in full-length (171 nt) transcripts and a concomitant increase in truncated transcripts (103 to 148 nt) was observed in assays designed to monitor the effects of TFOs on T3 polymerase elongation ( Figure 5A and 5B). Little to no decrease in full-length RNA transcript was observed when pBSFMLV DNA was pre-incubated with 4xlO" 6 M of the control oligonucleotide G101-50 ( Figure 5) .
In order to demonstrate that triple helix formation was necessary for the generation of the truncated transcripts, 50 mM KC1 was added to the pre-incubation and in vitro transcription buffer. In the presence of KC1, the measured K D of FMLV2ap for the target weakened 100-fold, from 2 X10"^ to 3 X 10" 7 M (Figures 1 and 3) . In these experiments, if FMLV2ap was allowed to pre-incubate with p275A DNA before the transcription reaction, then no decrease in full-length transcript or accumulation of the attenuated species was observed (Figure 7) . The control oligonucleotide FMLV2p had the same effect on transcription as FMLV2ap under these assay conditions (Figure 7) .
To determine whether the observed inhibitory effect of the oligonucleotides was dependent on interaction of the oligonucleotide with the DNA template, the oligonucleotides were added to the reaction mix at the same time as T7 polymerase. The results of this experiment ( Figure 7) show a decrease in fulllength transcripts without a concomitant increase in a truncated RNA species when FMLV2ap was added to the standard Qow salt) reaction mix. However, when 50 mM KC1 was added to the reaction mix, and oligonucleotides were added at the same time as the T7 polymerase, then no decrease in full-length transcript was observed (Figure 7) . The data presented in all the transcription assays presented above were consistent over multiple repetitions. 
Percent 131 Base Transcript* 100 % 132 % 83 % 127 % 120 % 86 % 83 % 100 % 60 % 83 % 53 % 27 % 97 % 79 % "The values presented are the average of two or more experiments.
•"FMLVlp is a shorter version of FMLV2p (26 nucleotides in length) and spans nucleotides 956 to 931 of the FMLV genome. P-labeled, full-length mRNA transcripts (131 or 171 nucleotides long) were removed from the gel and then quantitated by measuring the radioactivity in a scintillation counter. Oligonucleotides were pre-incubated with plasmid DNA as described in (A), using either p275A (T7 promoter) or pBSFMLV (T3 promoter). In column 1, no oligonucleotide was added to the transcription mix. Columns 2 through 5 contain the results obtained when decreasing amounts of FMLV2ap (2 x 10"^ to 2 x KT'M) were used. Column 6 presents die results obtained when only G101-50 (4x 10" 6 M) was pre-incubated with template DNA. The molecular size standards are the same as described in the legend to 
DISCUSSION
The data described in these experiments demonstrate that a triple helical DNA complex can, when positioned downstream from the either the bacteriophage T7 or T3 promoter, act as an attenuator of transcription in defined buffer conditions. Most experiments were conducted using p275A because of the welldocumented ability of T7 polymerase to process through molecular blocks such as noncatalytic EcoRl mutants and mammalian RNA polymerase IE (16) or the lac repressor (17, 18) . These same factors act to block E.coli RNA polymerase and eukaryotic RNA polymerase II. The ability of the TFO to cause attenuation of this polymerase demonstrates a strong interaction with the target duplex. The recombinant vector containing the T3 promoter was used because the distance, in nucleotides, between the target duplex and the T3 promoter was over 100 bp, whereas the distance between the T7 promoter and the TFO target was only 60 bp. Observations of transcription attenuation using pBSFMLV as a template would help rule out the possibility that TFOs, when bound to a duplex target downstream of the mRNA start site, interfered with the initiation of transcription.
The triple helix-forming oligonucleotide, when pre-incubated with target duplex DNA at roughly 1:1 effector to target ratios (10~7M oligonucleotide), significantly reduced full-length transcripts and caused the accumulation of an RNA product similar in size to that of the predicted truncated transcript. A shorter version of FMLV2ap (FMLVlap which was 26 nt in length) was also able to inhibit transcription with an accumulation of a truncated transcript of the predicted size (data not shown). However, the observed attenuation effect was dependent on the buffer conditions used. When KCl was added to the binding and reaction mix, a decrease in the ability of the TFO to bind with its target duplex (Figure 1 and 3) and a loss in the ability to attenuate transcription were observed. This change in activity may be the result of guanosine tetrad formation in the presence of KCl (15). The formation of these stable structures would effectively reduce the amount of oligonucleotide available to form triple helical structures.
In addition to triple helix-induced effects, alternative mechanisms of inhibition are evident. For example, the accumulation of truncated transcripts ( Figures 5 and 6 ) did not account for the total loss of full-length message. It is possible that a portion of the overall inhibition of full-length transcripts was a result of direct inhibition of the polymerase enzyme. The ability of oligonucleotides to directly inhibit enzyme activity is well-documented (19) , especially if the phosphodiester backbone of the oligonucleotide is modified to a phosphorothioate backbone. Experiments designed to elucidate the non sequence-dependent nature of the observed oligonucleotide-mediated inhibition of these enzymes are underway.
Recently, Maher (10) was able to inhibit the initiation but not the attenuation of T7 RNA polymerase activity using an antiparallel TFO. Several differences exist between that study and the experiments presented in this report. The differences include the pH of the buffer system, the addition of monovalent cation to the binding/reaction buffer, the target to effector ratios used, length (in nucleotides) between the mRNA start site and the position of the target duplex, and the overall size (in nts) of the oligonucleotides used. It is possible that the binding and transcription reaction conditions (which included the presence of monovalent cations) used in Maher's study (10) prevented the formation of a triple helix complex strong enough to attenuate RNA processing by the T7 promoter. The observations reported in this study, demonstrating that the presence of monovalent cations in the annealing/reaction buffer prevented attenuation of transcription, are consistent with Maher's (10) observations.
In another experimental system, Young et al. (9) used a parallel-binding ougonucleotide, which formed triple helical DNA at pH 7.2 in the presence of 50 mM KCl, to attenuate transcription in a eukaryotic system. Transcription attenuation was described as transitory in this system, in that the polymerase enzyme stalled in the region of a triple helix but could eventually 'read through' the blockage unless the TFO was covalently attached to the duplex (9). In our experiments, analysis of the transcription products reveals a banding pattern which is consistent with the position of the thymidine residues in the DNA template. Since UTP is the limiting nucleotide triphosphate in the reaction buffer, the position of these bands on the gel corresponds to where the polymerase has either stalled, due to lack of substrate, or has actually dissociated from the transcription complex, leaving a truncated transcript. The attenuation effect observed using FMLV2ap may have been enhanced by the fact that the enzyme is processing more slowly in the regions adjacent to the thymidine residues. It is not known whether the attenuated transcripts result from a stalled complex in the region of the triple helix or if they in fact represent dissociation of the enzyme from the transcription complex.
The in vitro experimental system presented in this report shows that oligonucleotides can form triple helices in a sequence-specific fashion and that these triple helical DNA structures alone are capable of disrupting RNA polymerase processing. At the present time, however, DNA sequence constrains the targeting of TFOs to only protein binding sites within promoter regulatory regions of selected target genes. The inability of the TFO to interact with target duplexes under more physiologic conditions greatly reduces the utility of the oligonucleotide-based triple helix technology. While we have addressed, in part, the ability to extend effective targets for TFO design, much work needs to be done to maximize the effectiveness of this class of transcription inhibitors. One potential solution to stabilizing the interaction of a TFO with its target duplex in vivo would be to attach a cross-linking or intercalating agent to the TFO (9) . In addition, advances in this technology may lead the way to the creation of TFOs capable of binding to a greater variety of target sequences, instead of only to purine-rich stretches of DNA under physiologic salt conditions. All of these advances may help expand the applications of TFO technology.
